Cargando…
Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database
BACKGROUND: As a result of progress in diagnosis and treatment, there is a growing prevalence of metastatic breast cancer (MBC) with isolated CNS metastases. This study describes the largest-to-date real-life cohort of this clinical setting and compares it to other clinical presentations. METHODS: W...
Autores principales: | Carausu, Marcela, Carton, Matthieu, Cabel, Luc, Patsouris, Anne, Levy, Christelle, Verret, Benjamin, Pasquier, David, Debled, Marc, Gonçalves, Anthony, Desmoulins, Isabelle, Lecouillard, Isabelle, Bachelot, Thomas, Ferrero, Jean-Marc, Eymard, Jean-Christophe, Mouret-Reynier, Marie-Ange, Chevrot, Michaël, De Maio, Eleonora, Uwer, Lionel, Frenel, Jean-Sébastien, Leheurteur, Marianne, Petit, Thierry, Darlix, Amélie, Bozec, Laurence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883300/ https://www.ncbi.nlm.nih.gov/pubmed/35237352 http://dx.doi.org/10.1177/17588359221077082 |
Ejemplares similares
-
Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort
por: Frank, Sophie, et al.
Publicado: (2020) -
Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicenter real-life cohort
por: Moinard-Butot, Fabien, et al.
Publicado: (2022) -
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real‐world database
por: Mailliez, Audrey, et al.
Publicado: (2022) -
Association of Endocrine Therapy for HR+/ERBB2+ Metastatic Breast Cancer With Survival Outcomes
por: Carausu, Marcela, et al.
Publicado: (2022) -
Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes regimen: A multicentre retrospective observational study
por: Vasseur, Antoine, et al.
Publicado: (2022)